Epidemiologic classification of human papillomavirus types associated with cervical cancer.
- N. Muñoz, F. X. Bosch, C. Meijer
- MedicineNew England Journal of Medicine
- 6 February 2003
In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82Should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.
The causal relation between human papillomavirus and cervical cancer.
- F. X. Bosch, A. Lorincz, N. Muñoz, C. Meijer, K. Shah
- MedicineJournal of Clinical Pathology
- 1 April 2002
It is the right time for medical societies and public health regulators to consider the causal role of human papillomavirus infections in cervical cancer and to define its preventive and clinical implications.
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
- R. Herrero, X. Castellsagué, S. Franceschi
- Medicine, BiologyJournal of the National Cancer Institute
- 3 December 2003
HPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of The most common HPV type in genital cancers (HPV16) was also the most common in these tumors.
Primary liver cancer: worldwide incidence and trends.
- F. X. Bosch, J. Ribes, M. Diaz, R. Clèries
- MedicineGastroenterology
- 1 November 2004
The incidence of primary liver cancer is increasing in several developed countries, including the United States, and the increase will likely continue for some decades, the trend is a result of a cohort effect related to infection with hepatitis B and C viruses.
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
- F. X. Bosch, M. Manos, Keerti V. Shan
- Medicine, Biology
- 7 June 1995
The results confirm the role of genitalHPVs, which are transmitted sexually, as the central etiologic factor in cervical cancer worldwide and suggest that most genital HPVs are associated with cancer, at least occasionally.
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.
- F. X. Bosch, M. Manos, K. Shah
- Medicine, BiologyJournal of the National Cancer Institute
- 1995
The results confirm the role of genitalHPVs, which are transmitted sexually, as the central etiologic factor in cervical cancer worldwide and suggest that most genital HPVs are associated with cancer, at least occasionally.
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III…
- J. Paavonen, D. Jenkins, G. Dubin
- Medicine, BiologyThe Lancet
- 30 June 2007
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
- F. X. Bosch, A. Burchell, N. Muñoz
- BiologyVaccine
- 19 August 2008
Epidemiology of primary liver cancer.
- F. X. Bosch, J. Ribes, J. Borràs
- MedicineSeminars in liver disease (Print)
- 1999
The role of chronic infection with the Hepatitis B and hepatitis C viruses (HBV and HCV) in the etiology of LC is well established, and attributable risk estimates for LC for each of these hepatotropic viruses vary among countries but the combined effects of persistent HBV or HCV infections account for well over 80% of LC cases worldwide.
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective
- T. Yamada, M. Manos, C. Wheeler
- BiologyJournal of Virology
- 1 March 1997
Intatype human papillomavirus type 16 (HPV-16) sequence variation in tumor samples that were collected and analyzed in an international study of invasive cervical cancer may prove important for the determination of the risk of cervical neoplasia and for the design of HPV-16 vaccine strategies.
...
...